Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.
Moon HS, Matarese G, Brennan AM, Chamberland JP, Liu X, Fiorenza CG, Mylvaganam GH, Abanni L, Carbone F, Williams CJ, De Paoli AM, Schneider BE, Mantzoros CS.
Moon HS, et al. Among authors: williams cj.
Diabetes. 2011 Jun;60(6):1647-56. doi: 10.2337/db10-1791.
Diabetes. 2011.
PMID: 21617185
Free PMC article.
Clinical Trial.